145 related articles for article (PubMed ID: 38164737)
1. Bronchoalveolar lavage fluid assessment facilitates precision medicine for lung cancer.
Zhang H; Deng D; Li S; Ren J; Huang W; Liu D; Wang W
Cancer Biol Med; 2023 Dec; 21(3):230-51. PubMed ID: 38164737
[TBL] [Abstract][Full Text] [Related]
2. Discovery of potential protein biomarkers of lung adenocarcinoma in bronchoalveolar lavage fluid by SWATH MS data-independent acquisition and targeted data extraction.
Ortea I; Rodríguez-Ariza A; Chicano-Gálvez E; Arenas Vacas MS; Jurado Gámez B
J Proteomics; 2016 Apr; 138():106-14. PubMed ID: 26917472
[TBL] [Abstract][Full Text] [Related]
3. A rapid liquid biopsy of lung cancer by separation and detection of exfoliated tumor cells from bronchoalveolar lavage fluid with a dual-layer "PERFECT" filter system.
Li T; Liu Y; Zhang W; Lin L; Zhang J; Xiong Y; Nie L; Liu X; Li H; Wang W
Theranostics; 2020; 10(14):6517-6529. PubMed ID: 32483467
[TBL] [Abstract][Full Text] [Related]
4. Extracellular vesicle-derived DNA for performing EGFR genotyping of NSCLC patients.
Hur JY; Kim HJ; Lee JS; Choi CM; Lee JC; Jung MK; Pack CG; Lee KY
Mol Cancer; 2018 Jan; 17(1):15. PubMed ID: 29374476
[TBL] [Abstract][Full Text] [Related]
5. Metabolic profiling of potential lung cancer biomarkers using bronchoalveolar lavage fluid and the integrated direct infusion/ gas chromatography mass spectrometry platform.
Callejón-Leblic B; García-Barrera T; Grávalos-Guzmán J; Pereira-Vega A; Gómez-Ariza JL
J Proteomics; 2016 Aug; 145():197-206. PubMed ID: 27255828
[TBL] [Abstract][Full Text] [Related]
6. Cell-free DNA from bronchoalveolar lavage fluid (BALF): a new liquid biopsy medium for identifying lung cancer.
Zeng D; Wang C; Mu C; Su M; Mao J; Huang J; Xu J; Shao L; Li B; Li H; Li B; Zhao J; Jiang J
Ann Transl Med; 2021 Jul; 9(13):1080. PubMed ID: 34422992
[TBL] [Abstract][Full Text] [Related]
7. Development of new techniques and clinical applications of liquid biopsy in lung cancer management.
Chen K; He Y; Wang W; Yuan X; Carbone DP; Yang F
Sci Bull (Beijing); 2024 May; 69(10):1556-1568. PubMed ID: 38641511
[TBL] [Abstract][Full Text] [Related]
8. Quantitative proteomic analysis of bronchoalveolar lavage fluids from patients with small cell lung cancers.
Vu HM; Mohammad HB; Nguyen TNC; Lee JH; Do Y; Sung JY; Lee SH; Kim MS
Proteomics Clin Appl; 2023 Sep; 17(5):e2300011. PubMed ID: 36807835
[TBL] [Abstract][Full Text] [Related]
9. A prospective phase 2 study of expeditious
Kim IA; Hur JY; Kim HJ; Kim WS; Lee KY
Transl Lung Cancer Res; 2023 Jul; 12(7):1425-1435. PubMed ID: 37577304
[TBL] [Abstract][Full Text] [Related]
10. MS-Based Biomarker Discovery in Bronchoalveolar Lavage Fluid for Lung Cancer.
Matthiesen R
Proteomics Clin Appl; 2020 Jan; 14(1):e1900077. PubMed ID: 31631581
[TBL] [Abstract][Full Text] [Related]
11. Extracellular Vesicle-Associated miRNAs as a Biomarker for Lung Cancer in Liquid Biopsy.
He X; Park S; Chen Y; Lee H
Front Mol Biosci; 2021; 8():630718. PubMed ID: 33718435
[TBL] [Abstract][Full Text] [Related]
12. Genomic profiling of extracellular vesicle-derived DNA from bronchoalveolar lavage fluid of patients with lung adenocarcinoma.
Lee SE; Park HY; Hur JY; Kim HJ; Kim IA; Kim WS; Lee KY
Transl Lung Cancer Res; 2021 Jan; 10(1):104-116. PubMed ID: 33569297
[TBL] [Abstract][Full Text] [Related]
13. Extracellular vesicle-based EGFR genotyping in bronchoalveolar lavage fluid from treatment-naive non-small cell lung cancer patients.
Hur JY; Lee JS; Kim IA; Kim HJ; Kim WS; Lee KY
Transl Lung Cancer Res; 2019 Dec; 8(6):1051-1060. PubMed ID: 32010582
[TBL] [Abstract][Full Text] [Related]
14. Bronchoalveolar Lavage Fluid-Isolated Biomarkers for the Diagnostic and Prognostic Assessment of Lung Cancer.
Kalkanis A; Papadopoulos D; Testelmans D; Kopitopoulou A; Boeykens E; Wauters E
Diagnostics (Basel); 2022 Nov; 12(12):. PubMed ID: 36552956
[TBL] [Abstract][Full Text] [Related]
15. Assessment of Anti-tumor Efficacy of Osimertinib in Non-Small Cell Lung Cancer Patients by Liquid Biopsy Using Bronchoalveolar Lavage Fluid, Plasma, or Pleural Effusion.
Kim YJ; Ji WJ; Lee JC; Chun SM; Choi CM
Cancer Res Treat; 2022 Oct; 54(4):985-995. PubMed ID: 35038824
[TBL] [Abstract][Full Text] [Related]
16. Performance evaluation of detecting circulating tumor cells and tumor cells in bronchoalveolar lavage fluid in diagnosis of peripheral lung cancer.
Zhong CH; Tong D; Zhou ZQ; Su ZQ; Luo YL; Xing J; Bai YL; Guo SJ; Li SY
J Thorac Dis; 2018 Apr; 10(Suppl 7):S830-S837. PubMed ID: 29780629
[TBL] [Abstract][Full Text] [Related]
17. In-Depth Proteomic Analysis of Human Bronchoalveolar Lavage Fluid toward the Biomarker Discovery for Lung Cancers.
Sim SY; Choi YR; Lee JH; Lim JM; Lee SE; Kim KP; Kim JY; Lee SH; Kim MS
Proteomics Clin Appl; 2019 Sep; 13(5):e1900028. PubMed ID: 31119868
[TBL] [Abstract][Full Text] [Related]
18. Extracellular Vesicle-Based Bronchoalveolar Lavage Fluid Liquid Biopsy for EGFR Mutation Testing in Advanced Non-Squamous NSCLC.
Kim IA; Hur JY; Kim HJ; Kim WS; Lee KY
Cancers (Basel); 2022 May; 14(11):. PubMed ID: 35681723
[TBL] [Abstract][Full Text] [Related]
19. IL-11 and CCL-1: Novel Protein Diagnostic Biomarkers of Lung Adenocarcinoma in Bronchoalveolar Lavage Fluid (BALF).
Pastor MD; Nogal A; Molina-Pinelo S; Quintanal-Villalonga Á; Meléndez R; Ferrer I; Romero-Romero B; De Miguel MJ; López-Campos JL; Corral J; García-Carboner R; Carnero A; Paz-Ares L
J Thorac Oncol; 2016 Dec; 11(12):2183-2192. PubMed ID: 27524264
[TBL] [Abstract][Full Text] [Related]
20. Assessment of quantitative polymerase chain reaction for equine herpesvirus-5 in blood, nasal secretions and bronchoalveolar lavage fluid for the laboratory diagnosis of equine multinodular pulmonary fibrosis.
Pusterla N; Magdesian KG; Mapes SM; Zavodovskaya R; Kass PH
Equine Vet J; 2017 Jan; 49(1):34-38. PubMed ID: 26639080
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
